BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 50 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180,125 | -12.2% | 12,500 | 0.0% | 0.04% | -11.1% |
| Q2 2023 | $205,250 | -1.7% | 12,500 | 0.0% | 0.04% | -10.0% |
| Q1 2023 | $208,875 | +11.7% | 12,500 | 0.0% | 0.05% | -2.0% |
| Q3 2022 | $187,000 | -8.8% | 12,500 | 0.0% | 0.05% | -1.9% |
| Q2 2022 | $205,000 | -18.3% | 12,500 | 0.0% | 0.05% | 0.0% |
| Q1 2022 | $251,000 | -20.8% | 12,500 | 0.0% | 0.05% | +8.3% |
| Q4 2021 | $317,000 | -5.9% | 12,500 | 0.0% | 0.05% | -33.3% |
| Q3 2021 | $337,000 | -6.9% | 12,500 | 0.0% | 0.07% | -2.7% |
| Q2 2021 | $362,000 | +10.0% | 12,500 | 0.0% | 0.07% | +1.4% |
| Q1 2021 | $329,000 | -8.1% | 12,500 | 0.0% | 0.07% | -9.9% |
| Q4 2020 | $358,000 | +20.1% | 12,500 | 0.0% | 0.08% | 0.0% |
| Q3 2020 | $298,000 | – | 12,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |